NATEC Medical launches a complete Peripheral Transluminal Angioplasty catheter range on OEM/OBL basis
Peripheral Arterial Disease (PAD) is the narrowing or blockage of the vessels that carry blood from the heart to the organs. It is primarily caused by the build-up of fatty plaque in the arteries, which is called atherosclerosis. PAD can occur in any blood vessel, but it is more common in the legs than the arms.
- PAD affects 12 to 14% of the general population.
- PAD affects 20% of patients over the age of 75.
- Over 27 million people in the U.S. and Europe are estimated to have PAD.
- 220,000 - 240,000 amputations per year in the U.S./Europe
- 49% of those amputations had no diagnostic testing for PAD
NATEC Medical announces today CE Mark approval of a complete catheter based solution for PAD treatment. Indeed, NATEC Medical is launching three different PTA platforms:
- Ebony 014” Rx and OTW
- Ebony 018” OTW
- Ebony 035” OTW
“Peripheral Vascular Diseases (PVDs) are clearly a steady growing indication, mainly due to the ageing of the population and an in-depth life style modification. The prevalence of the PVD increases with the age for both men and women. On top of that, when you add risk factors such as smoking, cholesterol and HBP we are clearly facing a health care situation” said Miroslav SECEROV, NATEC Medical Sales & Marketing VP. “Angioplasty is currently one of the most efficient treatment, doing as well as surgery and even better in some specific cases, but the choice of the primary device is, and will remain critical. Physicians need to have several options available and a complete treatment solution”.
Having the CE mark on Ebony range is the first step of NATEC Medical global regulatory approach, where 510k & ANVISA applications are as important as the width of the range. The 510k approval on the full range is expected by Q3 2014.
About NATEC Medical
Over the past 15 years, the Mauritius based PTCA and PTA balloon catheters manufacturer and distributor Natec Medical has proven to be the Global Partner for OEM medical devices market including Drug Eluting Balloon platforms, to prestigious clients who place their trust in our expertise and quality products. New orientations are driven by strategic business alliances, extended product portfolios and new value services, amongst which a complete crimping department with all the latest machines available. NATEC Medical is a privately held company.
Miroslav SECEROV – VP Sales & Marketing Maeva Building
Ebène Business Park
Tel : +230 52 52 37 52 / +33 688 06 23 38
Skype : miroslav.secerov